Atorvastatin Calcium
Product Images NDC 68071-2871

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2871). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2871 3)

Atorvastatin Calcium 10mg tablets packaging label from NuCare Pharmaceuticals, Inc. It contains 30 elliptical white tablets debossed with 'RX 12' on one side. The label includes manufacturing details by Sun Pharmaceutical Industries Limited, Mohali, India, dosage instructions, warnings, and barcode data. The product is Rx only with controlled storage temperature instructions.*

FDA Label Image

Structure (Image 01)

Chemical structure of Atorvastatin Calcium showing the molecular arrangement including phenyl groups, fluorophenyl, hydroxyl groups, and calcium ions (Ca2+). The diagram depicts the calcium salt form with associated water molecules.*

FDA Label Image

Figure1 (Image 02)

A cumulative incidence line graph comparing Atorvastatin and placebo over 3.5 years. The y-axis shows cumulative incidence percentage from 0.0 to 4.0, and the x-axis shows time in years from 0.0 to 3.5. The solid line represents Atorvastatin and the dashed line represents placebo, with Atorvastatin showing a lower cumulative incidence throughout the period.*

FDA Label Image

Figure 2 (Image 03)

A line graph showing cumulative hazard percentages over time, comparing placebo and atorvastatin treatments. The x-axis represents years of follow-up up to 5 years, and the y-axis shows cumulative hazard percentages up to 15%. The graph includes hazard ratio (HR 0.63) with confidence interval and p-value, illustrating lower cumulative hazard for atorvastatin compared to placebo throughout the follow-up period.*

FDA Label Image

Figure 3 (Image 04)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time between two doses of atorvastatin, 10 mg and 80 mg. The x-axis represents time in years up to 5 years, and the y-axis shows the percentage of subjects. The graph includes hazard ratio data with statistical significance indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.